Stericycle Q4 Adj. EPS $0.54 Beats $0.47 Estimate, Sales $652.00M Miss $657.93M Estimate
Portfolio Pulse from Benzinga Newsdesk
Stericycle (NASDAQ:SRCL) reported Q4 adjusted EPS of $0.54, surpassing the $0.47 estimate, but its sales of $652M fell short of the $657.93M forecast. This represents a 10% decrease in earnings and a 2.74% drop in sales from the same period last year.
February 28, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Stericycle's Q4 adjusted EPS exceeded expectations, but sales missed estimates with a year-over-year decrease in both metrics.
While the beat on the EPS estimate is positive, the miss on sales and the year-over-year decrease in both earnings and sales could temper investor enthusiasm. The mixed results present a neutral outlook in the short term as investors weigh the positive earnings surprise against the sales miss and overall declines.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100